Maravai LifeSciences Holdings, Inc. (MRVI) vs Pharvaris N.V. (PHVS)
A side-by-side comparison of Maravai LifeSciences Holdings, Inc. and Pharvaris N.V. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MRVI
Maravai LifeSciences Holdings, Inc.
$7.85HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
PHVS
Pharvaris N.V.
$31.12HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — MRVI vs PHVS
growth of $100 · dividends reinvested · last 6yMRVI -74.3% (-20.2%/yr)PHVS +5.1% (+0.8%/yr)PHVS compounded faster over this window
MRVI PHVS
MRVI vs PHVS: by the numbers
- •PHVS is the larger company ($2.17B vs $2.17B market cap).
- •Both run net losses; PHVS's is the smaller (0.00% vs -37.07% net margin).
Metrics side by side
Valuation
| Metric | MRVI | PHVS |
|---|---|---|
| P/S ratio | 10.39 | N/A |
| P/B ratio | 10.60 | 6.33 |
| EV / EBITDA | 15.02 | N/A |
Profitability
| Metric | MRVI | PHVS |
|---|---|---|
| Gross margin | 17.98% | 0.00% |
| Operating margin | -3.63% | 0.00% |
| Net margin | -37.07% | 0.00% |
| ROE | -37.82% | -57.96% |
| ROIC | 16.96% | -61.74% |
Growth (annualized)
| Metric | MRVI | PHVS |
|---|---|---|
| Revenue CAGR (5Y) | -17.68% | N/A |
| Total return CAGR (5Y) | -27.63% | 11.45% |
Frequently asked
- How have MRVI and PHVS total returns compared?
- Over the past 5 years, MRVI delivered -27.63% and PHVS delivered 11.45% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.